Study Stopped
sponsor funding
sponsor funding
Sponsor study identifier
observational
40
1 country
1
Study Start
December 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this research study is to perform serial magnetocardiographs (MCG)and cardiovascular risk factor assessments on individuals with no symptoms or history of heart disease. This small sized study of MCG in healthy individuals will allow for data collection for power analysis for a larger prospective trial. Volunteers are not compensated or paid.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2007
Date type not reportedThis date has not been verified as actual or estimated.
December 12, 2007
Actual (reported)December 13, 2007
Actual (reported)November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Subjects without any cardiovascular risk factors: 1. Age ≥ 45 in men; Age ≥ 55 in women. 2. Hypertension: BP \> 140/90 mmHg or on BP meds. 3. Diabetes Mellitus: Known fasting blood sugar \>126 mg/dl or on DM meds. 4. Dyslipidemia: On lipid lowering medication or LDL ≥ 160 mg/dl in absence of other risk factors; ≥ 130 mg/dl if other non-diabetic risk factors; ≥ 100 mg/dl if diabetic. Known HDL \< 40 mg/dl. 5. Cigarette smoking (past or present). 6. Family history of premature CAD in first degree relatives: Age \< 55 in men; Age \< 65 in women.
Subjects with 1 cardiovascular risk factor (listed above)
Subjects with 2 cardiovascular risk factors (listed above)
Subjects with more than 2 cardiovascular risk factors (listed above)
individuals without symptoms or history of heart disease
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Kirsten Tolstrup, MD
Cedars-Sinai Medical Center
First Submitted
December 12, 2007
First Posted
December 13, 2007
Study Start
December 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers
Contact the study team to confirm eligibility.
Study Completion
December 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 17, 2009
Record last verified: 2009-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: